Modulation of Toll-Like Receptor 9 expression by antisense oligonucleotides

Details for Australian Patent Application No. 2009276743 (hide)

Owner Idera Pharmaceuticals, Inc.

Inventors Kandimalla, Ekambar R.; Putta, Mallikarjuna; Lakshmi, Bhagat; Wang, Daqing; Yu, Dong; Zhu, Fugang; Agrawal, Sudhir

Agent Freehills

Pub. Number AU-A-2009276743

PCT Pub. Number WO2010/014572

Priority 61/084,091 28.07.08 US

Filing date 28 July 2009

Wipo publication date 4 February 2010

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

3 February 2011 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Lakshmi, Bhagat to Bhagat, Lakshmi

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/014572 Priority application(s): WO2010/014572

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009276744-Anti-malarial compounds

2009276721-Systems and methods for computerized interactive skill training